Dextrose 5%

Manufacturer
Huaren Pharmaceutical Co., Ltd.
Effective date
2025-11-07
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
2
Source
monthly-update
Hydrated at
2026-06-03 17:41:37

Label at a glance#

ProductDextrose 5%
Active ingredientANHYDROUS DEXTROSE
Label structure27 sections

Storage and handling

Sealed storage

Label contents#

Full prescribing information#

GLUCOSE (Dextrose) INJECTION, USP BAG

SPL UNCLASSIFIED SECTION

Instructions for Glucose (Dextrose) Injection

Please read the instructions carefully and use under the guidance of a physician.

Check carefully before use. Do not use if leakage is found, the drug liquid is unclear, or there are visible particles.

INGREDIENTS

DESCRIPTION SECTION

This product is a sterilized aqueous solution of glucose.

General Name: Glucose injection

Molecular formula: C6H12O6·H2O

Molecular weight: 198.17

Auxiliary material name: Dilute hydrochloric acid

CHARACTER

SPL UNCLASSIFIED SECTION

This product is colorless or almost colorless clear liquid.

INDICATIONS

INDICATIONS & USAGE SECTION

(1) Energy and fluid supplementation;It is used for underfeeding or massive fluid loss caused by various reasons (such as vomiting, diarrhea, etc.), total intravenous nutrition, and starvation ketosis.

(2) Drug diluents.

SPECIFICATION

DESCRIPTION SECTION

(1)50ml:2.5g(2)50ml:5g(3)100ml:5g(4)100ml:10g(5)250ml:12.5g(6)250ml:25g(7)500ml:25g(8)500ml:50g(9)1000ml:50g(10)1000ml:100g

USAGE AND DOSAGE

DOSAGE & ADMINISTRATION SECTION

Intravenous infusion. Medication as prescribed.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

1.Eating less, long-term simple supply of glucose solution can appear hypokalemia, hyponatremia and other electrolyte disorders. 2.Excessive infusion of this product may cause palpitations, arrhythmia, dyspnea, and even acute left heart failure in patients with cardiac insufficiency.

3.Hypophosphatemia is easy to occur when combined with insulin without paying attention to phosphate supplement.

4.Phlebitis may occur at the injection site.

【Taboos】

1. Uncontrolled diabetic ketoacidosis;

2. Hyperglycemic nonketotic hyperosmolar state.

PRECAUTIONS

PRECAUTIONS SECTION

1. Periodic paralysis, hypokalemia patients should be used with caution;

2. Stress or glucocorticoid induced hyperglycemia should be used with caution; Patients with edema, cardiac and renal insufficiency and liver cirrhosis ascites are prone to water retention, and the infusion volume should be controlled. Drip velocity should be controlled especially in patients with cardiac insufficiency.

3. Should be carefully checked before use, such as found leakage, solution turbidity, foreign bodies, etc., discarded.

4. Should be used in sterile conditions.

MEDICATION IN PREGNANT WOMEN AND LACTATING WOMEN

PREGNANCY SECTION

Too fast and too much fluid infusion may cause palpitation, arrhythmia and even acute left heart failure.

MEDICATION IN CHILDREN

PEDIATRIC USE SECTION

Too fast and too much fluid infusion may cause palpitation, arrhythmia and even acute left heart failure.

MEDICATION IN THE ELDERLY

GERIATRIC USE SECTION

Too fast and too much fluid infusion may cause palpitation, arrhythmia and even acute left heart failure.

DRUG INTERACTIONS

DRUG INTERACTIONS SECTION

The experiment was not performed and no reliable reference was available.

DRUG OVERDOSE

OVERDOSAGE SECTION

The experiment was not performed and no reliable reference was available.

PHARMACOLOGY AND TOXICOLOGY

CLINICAL PHARMACOLOGY SECTION

Glucose is an important nutrient component of the human body. Every 1 gram of glucose can produce 4 kilocalories of heat energy, so it is used to supplement heat.

PHARMACOKINETICS

PHARMACOKINETICS SECTION

It can be converted into glycogen and fat for storage. The ability of a normal human body to utilize glucose is 6mg/kg per minute.

STORAGE

STORAGE AND HANDLING SECTION

Sealed storage

VALIDITY

SPL UNCLASSIFIED SECTION

(1) The validity period of 250ml and 500ml products is 36 months.

(2) The validity period of 50ml, 100ml and 1000ml products is 24 months.

PACKAGE

HOW SUPPLIED SECTION

1. Plastic infusion bag (non-PVC co-extrusion film, double hard pipe, easy to break apart, double valve and double plug). 50ml/ bag, 100ml/ bag, 250ml/ bag, 500ml/ bag, 1000ml/ bag. 2

. Plastic infusion bag (non-PVC co-extruded film, double hard tube, easy to break apart, double valve double plug, double layer sterile packaging). 50ml/ bag, 100ml/ bag, 250ml/ bag, 500ml/ bag, 1000ml/ bag.

OTHER INFORMATION

SPL UNCLASSIFIED SECTION

【Executive standard】

Pharmacopoeia of the People's Republic of China (2020, Volume II)

【Pharmaceutical marketing authorization holder】

Name: Huaren Pharmaceutical Co., Ltd. Registered Address: No. 187, Zhuzhou Road, Qingdao High-tech Park

【Manufacturer】Enterprise Name: Huaren Pharmaceutical Co., Ltd. Production Address: No. 187, Zhuzhou Road, Qingdao High-tech Park Zip code: 266101 Telephone number: 0532-67709071 0532-67709728 Fax number: 0532-88702625

HEALTH CARE PROVIDER LETTER pg.1

HEALTH CARE PROVIDER LETTER SECTION

HEALTH CARE PROVIDER LETTER pg.1HEALTH CARE PROVIDER LETTER pg.1

HEALTH CARE PROVIDER LETTER pg.2

HEALTH CARE PROVIDER LETTER SECTION

HEALTH CARE PROVIDER LETTER pg.2HEALTH CARE PROVIDER LETTER pg.2

HEALTH CARE PROVIDER LETTER pg.3

HEALTH CARE PROVIDER LETTER SECTION

HEALTH CARE PROVIDER LETTER pg.3HEALTH CARE PROVIDER LETTER pg.3

PACKAGE LABEL– Dextrose 5% 50 mL Bag Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Dextrose 5% 50 mL Bag LabelDextrose 5% 50 mL Bag Label

PACKAGE LABEL– Dextrose 5% 100 mL Bag Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Dextrose 5% 100 mL Bag LabelDextrose 5% 100 mL Bag Label

PACKAGE LABEL-Dextrose 5% 500 mL Bag Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Dextrose 5% 500 mL Bag LabelDextrose 5% 500 mL Bag Label

PACKAGE LABEL-Dextrose 5% 250 mL Bag Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Dextrose 5% 250 mL Bag LabelDextrose 5% 250 mL Bag Label

PACKAGE LABEL-Dextrose 5% 1000 mL Bag Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Dextrose 5% 1000 mL Bag LabelDextrose 5% 1000 mL Bag Label

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
cb89b86a-369e-4204-8910-ae797c503af3Product name120230706
d4880ace-a516-8c47-8dfd-73a4ba5887d7Product name220180830
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 3 matching rows.

NDC Codes#

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
NameUNIIKind
WATER059QF0KO0RIACT
ANHYDROUS DEXTROSE5SL0G7R0OKACTIB

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
12025-04-24full-release2026-05-31 21:34:24

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
45a00886-52fd-bc6b-e063-6294a90ae41f338c7b6f-d3e0-6223-e063-6294a90a420a2025-12-10Adverse reactionsExact identifier
spl set id: 338c7b6f-d3e0-6223-e063-6294a90a420a

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.